A 58-year-old patient with rheumatoid arthritis develops dyspnea and sharp chest pain; chest x-ray shows a small effusion and nodules. The most appropriate treatment is which?

Prepare effectively for the Physician Assistant Clinical Knowledge Rating and Assessment Tool (PACKRAT) 1 Exam with comprehensive resources, flashcards, and detailed explanations. Ace your test with ease!

Multiple Choice

A 58-year-old patient with rheumatoid arthritis develops dyspnea and sharp chest pain; chest x-ray shows a small effusion and nodules. The most appropriate treatment is which?

Explanation:
The situation reflects inflammatory pleuritis (serositis) from rheumatoid arthritis, which causes sharp, pleuritic chest pain often with a small pleural effusion and dyspnea. Treating the inflammation of the pleura is key, and nonsteroidal anti-inflammatory drugs are first-line to reduce prostaglandin production and ease pain and inflammation. Indomethacin is a potent NSAID well-suited for RA-related serositis and pleuritis, making it the most appropriate choice here. Acetaminophen lacks anti-inflammatory effects and wouldn’t adequately address pleural inflammation. Amoxicillin would target infection, not inflammatory serositis, and a bronchodilator like albuterol isn’t relevant to pleural inflammation.

The situation reflects inflammatory pleuritis (serositis) from rheumatoid arthritis, which causes sharp, pleuritic chest pain often with a small pleural effusion and dyspnea. Treating the inflammation of the pleura is key, and nonsteroidal anti-inflammatory drugs are first-line to reduce prostaglandin production and ease pain and inflammation. Indomethacin is a potent NSAID well-suited for RA-related serositis and pleuritis, making it the most appropriate choice here. Acetaminophen lacks anti-inflammatory effects and wouldn’t adequately address pleural inflammation. Amoxicillin would target infection, not inflammatory serositis, and a bronchodilator like albuterol isn’t relevant to pleural inflammation.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy